Chemical giant Bayer has raised its sales estimate to 4-5% after strong sales during Q2, including the higest ever quarterly sales for the Bayer MaterialScience (BMS) division. Overall sales went up 10% to €10.2bn and Ebitda rose 6.7& to €2.2bn. Positive currency effects contributed around €70m to this figure, says Bayer. For the first half of the year, Bayer’s overall sales climbed by 8.4% to €20.2bn. The emerging markets - Asia (excluding Japan), Latin America, Eastern Europe, Africa and the Middle East – showed stronger growth (a 6.4% increase in sales) compared to industrialized countries (3.6%).